Suchergebnisse - "botox"

PubPharm (54)

1

Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants : A meta-analysis

enthalten in: JAAD international | 2024

von Brin, M. | De Boulle, K. | Liew, S. | +8

2

Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis : An unnecessary precaution

enthalten in: Journal of the American Academy of Dermatology | 2023

von Labadie, J. | Dover, J.

3

Mitigation of risk of botulinum toxin A-induced blepharoptosis with hyperconcentrated glabellar injections

enthalten in: Journal of the American Academy of Dermatology | 2023

von Ghanian, S. | Wambier, S. | Wambier, C.

4

Drugs for migraine

enthalten in: The Medical letter on drugs and therapeutics | 2023

5

Comparison table : Some drugs for migraine prevention in adults

enthalten in: The Medical letter on drugs and therapeutics | 2023

6

Drugs for overactive bladder

enthalten in: The Medical letter on drugs and therapeutics | 2023

7

Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine : A meta-analysis on 10 years of real-world data

enthalten in: Cephalalgia : an international journal of headache | 2022

von Lanteri-Minet, M. | Ducros, A. | Francois, C. | +3

8

Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis

enthalten in: Toxins | 2022

von Brami-Cherrier, K. | Chernavsky, A. | You, H. | +3

9

Treatment of segmental continuous hypertrophic myokymia of the limb with botulinum A toxin

enthalten in: SAGE open medical case reports | 2022

von Yousaf, M. | Ghani, M. | D'Aguiar Rosa, T. | +3

10

Atogepant (Qulipta) for migraine prevention

enthalten in: The Medical letter on drugs and therapeutics | 2021

1
2
3
4
5
6
Nächster »
[6]